Loading…

Glycyrrhizic acid derivatives as Dengue virus inhibitors

[Display omitted] •It is the first report to display structure-anti-DENV activity relationships of Glycyrrhizic acid (GL) derivatives.•GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 have been identified as potent DENV2 inhibitors.•GL derivatives 13 and 17 showed lower IC50 values (1...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters 2019-10, Vol.29 (20), p.126645-126645, Article 126645
Main Authors: Baltina, Lidia A., Tasi, Yan-Ting, Huang, Su-Hua, Lai, Hsueh-Chou, Baltina, Lia A., Petrova, Svetlana F., Yunusov, Marat S., Lin, Cheng-Wen
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c455t-25980d0bee0435991b55aa9a858bf079cb4259463787ef7791052cb2dea98e8d3
cites cdi_FETCH-LOGICAL-c455t-25980d0bee0435991b55aa9a858bf079cb4259463787ef7791052cb2dea98e8d3
container_end_page 126645
container_issue 20
container_start_page 126645
container_title Bioorganic & medicinal chemistry letters
container_volume 29
creator Baltina, Lidia A.
Tasi, Yan-Ting
Huang, Su-Hua
Lai, Hsueh-Chou
Baltina, Lia A.
Petrova, Svetlana F.
Yunusov, Marat S.
Lin, Cheng-Wen
description [Display omitted] •It is the first report to display structure-anti-DENV activity relationships of Glycyrrhizic acid (GL) derivatives.•GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 have been identified as potent DENV2 inhibitors.•GL derivatives 13 and 17 showed lower IC50 values (1.2–1.3 μM) against DENV2 infectivity in Vero E6 cells than GL (IC50 8.1 μM). Dengue virus (DENV) is one of the most geographically distributed pathogenic flaviviruses transmitted by mosquitoes Aedes sps. In this study, the structure-antiviral activity relationships of Glycyrrhizic acid (GL) derivatives was evaluated by the inhibitory assays on the cytopathic effect (CPE) and viral infectivity of DENV type 2 (DENV2) in Vero E6 cells. GL (96% purity) had a low cytotoxicity to Vero E6 cells, inhibited DENV2-induced CPE, and reduced the DENV-2 infectivity with the IC50 of 8.1 μM. Conjugation of GL with amino acids or their methyl esters and the introduction of aromatic acylhydrazide residues into the carbohydrate part strongly influenced on the antiviral activity. Among compounds tested GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 were found as potent anti-DENV2 inhibitors (IC50 1.2–1.3 μM). Therefore, modification of GL is a perspective way in the search of new antivirals against DENV2 infection.
doi_str_mv 10.1016/j.bmcl.2019.126645
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7172207</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X19305906</els_id><sourcerecordid>2290839986</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-25980d0bee0435991b55aa9a858bf079cb4259463787ef7791052cb2dea98e8d3</originalsourceid><addsrcrecordid>eNp9kMFq3DAQhkVJaTZpX6CH4GMu3oxkyZIgFMqm3RQCvSTQm5Dl2d1ZvHYq2YbN09fLJqG55DSH-f5_ho-xrxzmHHh5tZ1Xu9DMBXA756IspfrAZlyWMi8kqBM2A1tCbqz8c8rOUtoCcAlSfmKnBVfcFlrNmFk2-7CPcUNPFDIfqM5qjDT6nkZMmU_ZDbbrAbOR4pAyajdUUd_F9Jl9XPkm4Zfnec4efv64X9zmd7-Xvxbf7_IglepzoayBGipEkIWylldKeW-9UaZagbahkhMiy0IbjSutLQclQiVq9NagqYtz9u3Y-zhUO6wDtn30jXuMtPNx7zpP7u2mpY1bd6PTXAsBeiq4fC6I3d8BU-92lAI2jW-xG5ITwoIprDXlhIojGmKXUsTV6xkO7qDcbd1BuTsod0flU-ji_wdfIy-OJ-D6COCkaSSMLgXCNmBNEUPv6o7e6_8HYgOS9A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2290839986</pqid></control><display><type>article</type><title>Glycyrrhizic acid derivatives as Dengue virus inhibitors</title><source>ScienceDirect Journals</source><creator>Baltina, Lidia A. ; Tasi, Yan-Ting ; Huang, Su-Hua ; Lai, Hsueh-Chou ; Baltina, Lia A. ; Petrova, Svetlana F. ; Yunusov, Marat S. ; Lin, Cheng-Wen</creator><creatorcontrib>Baltina, Lidia A. ; Tasi, Yan-Ting ; Huang, Su-Hua ; Lai, Hsueh-Chou ; Baltina, Lia A. ; Petrova, Svetlana F. ; Yunusov, Marat S. ; Lin, Cheng-Wen</creatorcontrib><description>[Display omitted] •It is the first report to display structure-anti-DENV activity relationships of Glycyrrhizic acid (GL) derivatives.•GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 have been identified as potent DENV2 inhibitors.•GL derivatives 13 and 17 showed lower IC50 values (1.2–1.3 μM) against DENV2 infectivity in Vero E6 cells than GL (IC50 8.1 μM). Dengue virus (DENV) is one of the most geographically distributed pathogenic flaviviruses transmitted by mosquitoes Aedes sps. In this study, the structure-antiviral activity relationships of Glycyrrhizic acid (GL) derivatives was evaluated by the inhibitory assays on the cytopathic effect (CPE) and viral infectivity of DENV type 2 (DENV2) in Vero E6 cells. GL (96% purity) had a low cytotoxicity to Vero E6 cells, inhibited DENV2-induced CPE, and reduced the DENV-2 infectivity with the IC50 of 8.1 μM. Conjugation of GL with amino acids or their methyl esters and the introduction of aromatic acylhydrazide residues into the carbohydrate part strongly influenced on the antiviral activity. Among compounds tested GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 were found as potent anti-DENV2 inhibitors (IC50 1.2–1.3 μM). Therefore, modification of GL is a perspective way in the search of new antivirals against DENV2 infection.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2019.126645</identifier><identifier>PMID: 31519375</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Anti-Inflammatory Agents - chemistry ; Anti-Inflammatory Agents - pharmacology ; Antiviral activity ; Antiviral Agents - chemistry ; Antiviral Agents - pharmacology ; Cell Survival - drug effects ; Chlorocebus aethiops ; Cytopathogenic Effect, Viral - drug effects ; Dengue - drug therapy ; Dengue virus ; Dengue Virus - drug effects ; Derivatives ; Glycyrrhizic acid ; Glycyrrhizic Acid - analogs &amp; derivatives ; Glycyrrhizic Acid - chemistry ; Glycyrrhizic Acid - pharmacology ; Humans ; Molecular Structure ; Small Molecule Libraries - chemistry ; Small Molecule Libraries - pharmacology ; Structure-Activity Relationship ; Vero Cells - drug effects ; Virus Replication - drug effects</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2019-10, Vol.29 (20), p.126645-126645, Article 126645</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><rights>2019 Elsevier Ltd. All rights reserved. 2019 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-25980d0bee0435991b55aa9a858bf079cb4259463787ef7791052cb2dea98e8d3</citedby><cites>FETCH-LOGICAL-c455t-25980d0bee0435991b55aa9a858bf079cb4259463787ef7791052cb2dea98e8d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31519375$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baltina, Lidia A.</creatorcontrib><creatorcontrib>Tasi, Yan-Ting</creatorcontrib><creatorcontrib>Huang, Su-Hua</creatorcontrib><creatorcontrib>Lai, Hsueh-Chou</creatorcontrib><creatorcontrib>Baltina, Lia A.</creatorcontrib><creatorcontrib>Petrova, Svetlana F.</creatorcontrib><creatorcontrib>Yunusov, Marat S.</creatorcontrib><creatorcontrib>Lin, Cheng-Wen</creatorcontrib><title>Glycyrrhizic acid derivatives as Dengue virus inhibitors</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>[Display omitted] •It is the first report to display structure-anti-DENV activity relationships of Glycyrrhizic acid (GL) derivatives.•GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 have been identified as potent DENV2 inhibitors.•GL derivatives 13 and 17 showed lower IC50 values (1.2–1.3 μM) against DENV2 infectivity in Vero E6 cells than GL (IC50 8.1 μM). Dengue virus (DENV) is one of the most geographically distributed pathogenic flaviviruses transmitted by mosquitoes Aedes sps. In this study, the structure-antiviral activity relationships of Glycyrrhizic acid (GL) derivatives was evaluated by the inhibitory assays on the cytopathic effect (CPE) and viral infectivity of DENV type 2 (DENV2) in Vero E6 cells. GL (96% purity) had a low cytotoxicity to Vero E6 cells, inhibited DENV2-induced CPE, and reduced the DENV-2 infectivity with the IC50 of 8.1 μM. Conjugation of GL with amino acids or their methyl esters and the introduction of aromatic acylhydrazide residues into the carbohydrate part strongly influenced on the antiviral activity. Among compounds tested GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 were found as potent anti-DENV2 inhibitors (IC50 1.2–1.3 μM). Therefore, modification of GL is a perspective way in the search of new antivirals against DENV2 infection.</description><subject>Animals</subject><subject>Anti-Inflammatory Agents - chemistry</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Antiviral activity</subject><subject>Antiviral Agents - chemistry</subject><subject>Antiviral Agents - pharmacology</subject><subject>Cell Survival - drug effects</subject><subject>Chlorocebus aethiops</subject><subject>Cytopathogenic Effect, Viral - drug effects</subject><subject>Dengue - drug therapy</subject><subject>Dengue virus</subject><subject>Dengue Virus - drug effects</subject><subject>Derivatives</subject><subject>Glycyrrhizic acid</subject><subject>Glycyrrhizic Acid - analogs &amp; derivatives</subject><subject>Glycyrrhizic Acid - chemistry</subject><subject>Glycyrrhizic Acid - pharmacology</subject><subject>Humans</subject><subject>Molecular Structure</subject><subject>Small Molecule Libraries - chemistry</subject><subject>Small Molecule Libraries - pharmacology</subject><subject>Structure-Activity Relationship</subject><subject>Vero Cells - drug effects</subject><subject>Virus Replication - drug effects</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kMFq3DAQhkVJaTZpX6CH4GMu3oxkyZIgFMqm3RQCvSTQm5Dl2d1ZvHYq2YbN09fLJqG55DSH-f5_ho-xrxzmHHh5tZ1Xu9DMBXA756IspfrAZlyWMi8kqBM2A1tCbqz8c8rOUtoCcAlSfmKnBVfcFlrNmFk2-7CPcUNPFDIfqM5qjDT6nkZMmU_ZDbbrAbOR4pAyajdUUd_F9Jl9XPkm4Zfnec4efv64X9zmd7-Xvxbf7_IglepzoayBGipEkIWylldKeW-9UaZagbahkhMiy0IbjSutLQclQiVq9NagqYtz9u3Y-zhUO6wDtn30jXuMtPNx7zpP7u2mpY1bd6PTXAsBeiq4fC6I3d8BU-92lAI2jW-xG5ITwoIprDXlhIojGmKXUsTV6xkO7qDcbd1BuTsod0flU-ji_wdfIy-OJ-D6COCkaSSMLgXCNmBNEUPv6o7e6_8HYgOS9A</recordid><startdate>20191015</startdate><enddate>20191015</enddate><creator>Baltina, Lidia A.</creator><creator>Tasi, Yan-Ting</creator><creator>Huang, Su-Hua</creator><creator>Lai, Hsueh-Chou</creator><creator>Baltina, Lia A.</creator><creator>Petrova, Svetlana F.</creator><creator>Yunusov, Marat S.</creator><creator>Lin, Cheng-Wen</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20191015</creationdate><title>Glycyrrhizic acid derivatives as Dengue virus inhibitors</title><author>Baltina, Lidia A. ; Tasi, Yan-Ting ; Huang, Su-Hua ; Lai, Hsueh-Chou ; Baltina, Lia A. ; Petrova, Svetlana F. ; Yunusov, Marat S. ; Lin, Cheng-Wen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-25980d0bee0435991b55aa9a858bf079cb4259463787ef7791052cb2dea98e8d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents - chemistry</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Antiviral activity</topic><topic>Antiviral Agents - chemistry</topic><topic>Antiviral Agents - pharmacology</topic><topic>Cell Survival - drug effects</topic><topic>Chlorocebus aethiops</topic><topic>Cytopathogenic Effect, Viral - drug effects</topic><topic>Dengue - drug therapy</topic><topic>Dengue virus</topic><topic>Dengue Virus - drug effects</topic><topic>Derivatives</topic><topic>Glycyrrhizic acid</topic><topic>Glycyrrhizic Acid - analogs &amp; derivatives</topic><topic>Glycyrrhizic Acid - chemistry</topic><topic>Glycyrrhizic Acid - pharmacology</topic><topic>Humans</topic><topic>Molecular Structure</topic><topic>Small Molecule Libraries - chemistry</topic><topic>Small Molecule Libraries - pharmacology</topic><topic>Structure-Activity Relationship</topic><topic>Vero Cells - drug effects</topic><topic>Virus Replication - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baltina, Lidia A.</creatorcontrib><creatorcontrib>Tasi, Yan-Ting</creatorcontrib><creatorcontrib>Huang, Su-Hua</creatorcontrib><creatorcontrib>Lai, Hsueh-Chou</creatorcontrib><creatorcontrib>Baltina, Lia A.</creatorcontrib><creatorcontrib>Petrova, Svetlana F.</creatorcontrib><creatorcontrib>Yunusov, Marat S.</creatorcontrib><creatorcontrib>Lin, Cheng-Wen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baltina, Lidia A.</au><au>Tasi, Yan-Ting</au><au>Huang, Su-Hua</au><au>Lai, Hsueh-Chou</au><au>Baltina, Lia A.</au><au>Petrova, Svetlana F.</au><au>Yunusov, Marat S.</au><au>Lin, Cheng-Wen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glycyrrhizic acid derivatives as Dengue virus inhibitors</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2019-10-15</date><risdate>2019</risdate><volume>29</volume><issue>20</issue><spage>126645</spage><epage>126645</epage><pages>126645-126645</pages><artnum>126645</artnum><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>[Display omitted] •It is the first report to display structure-anti-DENV activity relationships of Glycyrrhizic acid (GL) derivatives.•GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 have been identified as potent DENV2 inhibitors.•GL derivatives 13 and 17 showed lower IC50 values (1.2–1.3 μM) against DENV2 infectivity in Vero E6 cells than GL (IC50 8.1 μM). Dengue virus (DENV) is one of the most geographically distributed pathogenic flaviviruses transmitted by mosquitoes Aedes sps. In this study, the structure-antiviral activity relationships of Glycyrrhizic acid (GL) derivatives was evaluated by the inhibitory assays on the cytopathic effect (CPE) and viral infectivity of DENV type 2 (DENV2) in Vero E6 cells. GL (96% purity) had a low cytotoxicity to Vero E6 cells, inhibited DENV2-induced CPE, and reduced the DENV-2 infectivity with the IC50 of 8.1 μM. Conjugation of GL with amino acids or their methyl esters and the introduction of aromatic acylhydrazide residues into the carbohydrate part strongly influenced on the antiviral activity. Among compounds tested GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 were found as potent anti-DENV2 inhibitors (IC50 1.2–1.3 μM). Therefore, modification of GL is a perspective way in the search of new antivirals against DENV2 infection.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>31519375</pmid><doi>10.1016/j.bmcl.2019.126645</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2019-10, Vol.29 (20), p.126645-126645, Article 126645
issn 0960-894X
1464-3405
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7172207
source ScienceDirect Journals
subjects Animals
Anti-Inflammatory Agents - chemistry
Anti-Inflammatory Agents - pharmacology
Antiviral activity
Antiviral Agents - chemistry
Antiviral Agents - pharmacology
Cell Survival - drug effects
Chlorocebus aethiops
Cytopathogenic Effect, Viral - drug effects
Dengue - drug therapy
Dengue virus
Dengue Virus - drug effects
Derivatives
Glycyrrhizic acid
Glycyrrhizic Acid - analogs & derivatives
Glycyrrhizic Acid - chemistry
Glycyrrhizic Acid - pharmacology
Humans
Molecular Structure
Small Molecule Libraries - chemistry
Small Molecule Libraries - pharmacology
Structure-Activity Relationship
Vero Cells - drug effects
Virus Replication - drug effects
title Glycyrrhizic acid derivatives as Dengue virus inhibitors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T08%3A38%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glycyrrhizic%20acid%20derivatives%20as%20Dengue%20virus%20inhibitors&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Baltina,%20Lidia%20A.&rft.date=2019-10-15&rft.volume=29&rft.issue=20&rft.spage=126645&rft.epage=126645&rft.pages=126645-126645&rft.artnum=126645&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2019.126645&rft_dat=%3Cproquest_pubme%3E2290839986%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-25980d0bee0435991b55aa9a858bf079cb4259463787ef7791052cb2dea98e8d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2290839986&rft_id=info:pmid/31519375&rfr_iscdi=true